Thrombolytic Therapy of Pulmonary Thromboembolism in Probable Sporadic Creutzfeldt-Jakob Disease
Journal of the Korean Neurological Association
; : 405-408, 2009.
Article
em Ko
| WPRIM
| ID: wpr-188685
Biblioteca responsável:
WPRO
ABSTRACT
The effect of intravenous recombinant tissue plasminogen activator for patients with Creutzfeldt-Jakob disease (CJD) has yet to be determined. A woman with rapidly progressive cognitive decline, cerebellar dysfunction, and extrapyramidal symptoms, diagnosed as probable sporadic CJD, was complicated with pulmonary thromboembolism and systemic hypotension. Her vital signs were restored without brain parenchymal hemorrhage after intravenous thrombolysis. The presence of diffuse brain lesions in CJD did not increase the hemorrhagic complications associated with intravenous thrombolysis, which differs from an ischemic vascular event.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Embolia Pulmonar
/
Encéfalo
/
Terapia Trombolítica
/
Doenças Cerebelares
/
Síndrome de Creutzfeldt-Jakob
/
Encefalopatia Espongiforme Bovina
/
Ativador de Plasminogênio Tecidual
/
Sinais Vitais
/
Hemorragia
/
Hipotensão
Limite:
Female
/
Humans
Idioma:
Ko
Revista:
Journal of the Korean Neurological Association
Ano de publicação:
2009
Tipo de documento:
Article